The influence of the sample matrix on LC-MS/MS method development and analytical performance

Koster, R. A., 2015, [Groningen]: University of Groningen. 296 p.

Research output: ThesisThesis fully internal (DIV)Academic

Copy link to clipboard


  • Title_and_contents

    Final publisher's version, 176 KB, PDF document

  • Chapter_1

    Final publisher's version, 177 KB, PDF document

  • Chapter_2

    Final publisher's version, 632 KB, PDF document

  • Chapter_3.1

    Final publisher's version, 282 KB, PDF document

  • Chapter_3.2

    Final publisher's version, 1 MB, PDF document

  • Chapter_3.3

    Final publisher's version, 685 KB, PDF document

  • Chapter_3.4

    Final publisher's version, 586 KB, PDF document

  • Chapter_3.5

    Final publisher's version, 384 KB, PDF document

  • Chapter_3.6

    Final publisher's version, 316 KB, PDF document

  • Chapter_3.7

    Final publisher's version, 274 KB, PDF document

  • Chapter_3.8

    Final publisher's version, 684 KB, PDF document

  • Chapter_4

    Final publisher's version, 365 KB, PDF document

  • Chapter_5.1

    Final publisher's version, 1 MB, PDF document

  • Chapter_5.2

    Final publisher's version, 556 KB, PDF document

  • Chapter_6

    Final publisher's version, 164 KB, PDF document

  • Chapter_7

    Final publisher's version, 151 KB, PDF document

  • Appendices

    Final publisher's version, 228 KB, PDF document

  • Complete_thesis

    Final publisher's version, 4 MB, PDF document

  • Propositions

    Final publisher's version, 625 KB, PDF document

In order to provide personalized patient treatment, a large number of analytical procedures is needed to measure a large variety of drugs in various human matrices. The analytical technique used for this research is Liquid Chromatography coupled with triple quadrupole mass spectrometry (LC-MS/MS). Each patient setting may require a specific matrix. Sweat and hair samples may be used to monitor drug abuse. Therapeutic drug monitoring (TDM) performed with the use of blood and plasma samples may be suitable for in-patients, while dried blood spot (DBS) may be more suitable for outpatients. These alternative matrices make sampling less invasive. In addition, DBS reduces patient travelling time, because sampling can be performed at home. This provides more cost-efficient patient care. The use of DBS is very promising, but the investigated parameters showed not to be underestimated and need to be considered before performing patient analysis. In the near future, personalized patient treatment will not only comprehend personalized dosing of patients, but also a personalized choice of matrix which best suits the patients’ circumstances and optimal needs. In summary we can say that the used sample matrix affects the method development and analytical performance with LC-MS / MS. The influence of the matrix can result in altered stability of the substance, formation of complexes with other substances or binding of the substance with the sampling material. More insight in these matrix effects will lead to improved analytical methods and performance, but will above all improve patient care and research.
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
Award date25-Sep-2015
Place of Publication[Groningen]
Print ISBNs978-90-367-8023-0
Electronic ISBNs978-90-367-8022-3
Publication statusPublished - 2015

Download statistics

No data available

ID: 23558396